We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update - Nexus Underwriting

8 Oct 2021 07:00

RNS Number : 4082O
B.P. Marsh & Partners PLC
08 October 2021
 

Date: 8 October 2021

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Investee Company Update & Further Investment- Nexus Underwriting Management Limited

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist investor in early-stage financial services businesses, is pleased to announce that Nexus Underwriting Management Limited ("Nexus"), the independent specialty Managing General Agency ("MGA"), has successfully completed a refinancing exercise which sees £4m of loans repaid to B.P. Marsh over two years earlier than expected. Simultaneously to this refinancing, B.P. Marsh has acquired a further 2.49% shareholding in Nexus, from a founding shareholder.

 

1. Refinancing

 

Nexus has secured a new £70m banking facility from Barings LLC ("Barings"), the global investment manager. This facility will be utilised in two ways, with £50m being used to refinance existing debt and meet upcoming deferred consideration payments, with the balance available for new acquisitions.

 

As part of this fundraising, Nexus has repaid in full the £4m Loan Facility with B.P. Marsh, alongside the £40m Loan Facility with HPS Investment Partners LLC. The £4m Loan Facility was originally due to be repaid by 8th January 2024.

 

When Nexus raised these facilities with HPS and B.P. Marsh in 2017, Nexus' EBITDA was £5m, and the equity value of its business was £75m. For the 2021 financial year, Nexus is forecasting underlying EBITDA of £19m and has an internal equity value of £238m.

 

Since 2017, Nexus' underlying EBITDA has increased by 3.4x, and the equity value by 3.1x.

 

This financing provides Nexus with the opportunity to make further acquisitions and enter the next phase of its growth.

 

B.P. Marsh first invested in Nexus in August 2014; it has since grown from a Gross Written Premium of £55m to a projected figure of over £400m in 2021. Over the same period, Nexus has grown its EBITDA by over seven times.

 

Barings is an international investment management firm, with $382bn+ of Assets Under Management, over 2000 staff and offices in 16 countries.

 

2. Further Acquisition of Shares in Nexus

 

Alongside this fundraising, B.P. Marsh has acquired a further 100,000 shares in Nexus for £4m from Ian Whistondale, a founding non-management shareholder.

 

B.P. Marsh saw this as an opportunity to allow a founding shareholder to partially realise the value of his equity in Nexus, whilst enabling it to acquire a further 2.49% shareholding in Nexus.

 

Following this share purchase, the Group's fully diluted shareholding in Nexus has increased to 19.18%. B.P. Marsh is now the largest individual shareholder in Nexus, with management and employees continuing to own over 50% of the business.

 

Colin Thompson, Nexus Founder and Group CEO stated:-

 

"This debt facility provides Nexus with the ability to satisfy our long-term growth aspirations, increasing both Gross Written Premium and EBITDA via organic growth and from new acquisitions."

 

Dan Topping, Chief Investment Officer of the Company, commented:-

 

"With this successful debt raising Nexus is well set for its next phase of transformational growth, taking the business to $1billion of Gross Written Premium Income, and we are looking forward to working with them to further deliver significant equity value uplift.

 

"The Group first acquired a 5% in shareholding in Nexus in 2014, seeing this as a unique opportunity to structure a transaction whereby we would not only be able to increase our shareholding to our more usual percentage, but also to support and assist the management team at Nexus to grow the business significantly. As evidenced by their performance, management have achieved a tremendous amount and a considerable ongoing return for the Company."

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

 

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

 

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster

 

+44 (0)20 7886 2500

Financial PR & Investor Relations

 

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments.Several of the directors have worked with each other in previous roles, and all have worked with each other for more than ten years.

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLSIELDIIL
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.